← Open Payments lookup

SYDNEY DANIELSON: Open Payments

NPI 1477228880 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$674 in 34 payments from 19 companies in 2025. Trend: 2023 $584 · 2024 $425 · 2025 $674

Food & beverage: $674
CompanyPaymentsAmount
Novo Nordisk Inc5$102
AstraZeneca Pharmaceuticals LP4$79
ABBVIE INC.4$78
PFIZER INC.4$72
Amgen Inc.2$40
Lilly USA, LLC2$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$34
Gilead Sciences, Inc.1$27
TMS NeuroHealth Centers Inc.1$25
Boehringer Ingelheim Pharmaceuticals, Inc.1$22

Products named: Ozempic, JARDIANCE, VRAYLAR, AIRSUPRA, NURTEC ODT, CAPLYTA, TMS NeuroHealth Centers Inc., FARXIGA.

Industry payments across MD — which companies pay providers there.